Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Cash from Operating Activities | -224.86M | -84.07M | -159.38M | -244.3M | -324.23M | -149.16M | -284.1M | -351.09M |
Cash from Investing Activities | 206.69M | -186.86M | -190.6M | -140.4M | -502.52M | 98.05M | -24.05M | -226.44M |
Cash from Financing Activities | 313.45M | 52.69M | 95.62M | 115.2M | 595.12M | 573.71M | 707.83M | 715.29M |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Cash from Operating Activities | -17.61M | -22.32M | -25.51M | -41.62M | -157.56M | -183.92M | -224.86M | -324.23M |
Cash from Investing Activities | 21.99M | -22.01M | -380.08M | 30.71M | 159.78M | -5.06M | 206.69M | -502.52M |
Cash from Financing Activities | 14.45M | 173.81M | 314.34M | 235k | 5.09M | 171.24M | 313.45M | 595.12M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.